ArticleJournal for immunotherapy of cancer2024

Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.

Bixia Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.